Showing posts sorted by date for query STATE MONOPOLY CAPITALI$M. Sort by relevance Show all posts
Showing posts sorted by date for query STATE MONOPOLY CAPITALI$M. Sort by relevance Show all posts

Tuesday, September 22, 2026

MONOPOLY CAPITALI$M

How Bill Gates’ Billions Shape US Medical Research – OpEd


Image: Grok


September 23, 2026

By Paul Thacker

Key Takeaways:

On the eve of Bill Gates’s private congressional testimony, RealClearInvestigations cites NIH whistleblower emails arguing the Gates Foundation, via the Foundation for the NIH, has steered U.S. biomedical priorities since a 2003 $200 million gift and later joint workshops, trials, and grant alignment across multiple NIH programs. The foundation and NIH did not comment to RCI.

Documents describe Gates-first billing on federal-campus meetings, a 2015 Ebola alignment that hired McKinsey through FNIH, and a 2016 visit where Francis Collins escorted Gates past NIH police; Fauci moderated a panel and another covered gene-drive mosquito work Gates had seeded. FNIH later honored Gates (~$413 million) and Pfizer.

The piece also flags foundation investments (CureVac, a BioNTech stake later sold at a large gain) as blurring charity and profit, quotes an official on a “merging” of NIH and Gates, and notes Target Malaria’s Burkina Faso pause. Critics ask who elected Gates to set federal research direction.


Bill Gates has long been one of the most admired people in the world, especially since he stepped down from his role running Microsoft to devote himself and much of his fortune to philanthropy. That reputation has been tarnished recently, however, by revelations of the billionaire’s close relation with sex offender Jeffrey Epstein, and exposés on his own fraught relationships with women.

On the eve of Gates’ private testimony with Congress scheduled for tomorrow, a trove of federal whistleblower documents provided to RealClearInvestigations is renewing questions about how Gates money has bought what critics complain is an untoward influence on government health policy. For almost a quarter of a century, his main vehicle of power, the Bill and Melinda Gates Foundation, has donated hundreds of millions of dollars to the National Institutes of Health (NIH), allowing Gates to shape the direction of the country’s health strategy in ways that have benefitted his own priorities and pet causes while polishing his image as a benevolent global do-gooder.

At a time of growing concern about the power of billionaires such as Elon Musk, Jeff Bezos, and Sam Altman, Gates’ efforts stand out. Instead of lobbying federal agencies for specific policies, Gates leveraged his wealth to work inside the government, partnering with high-ranking NIH officials to steer taxpayer research funding and design scientific policies for several federal programs.


The cache of several dozen emails and documents, made public for the first time by an NIH whistleblower, reinforces previous reports detailing Gates’s extensive influence over U.S. biomedical research. During the height of the COVID pandemic, Kate Elder, a senior vaccines policy adviser for Doctors Without Borders, complained to Politico, “What makes Bill Gates qualified to be giving advice and advising the U.S. government on where they should be putting the tremendous resources?”

Emails and internal plans, for example, show that the NIH – the world’s largest funder of biomedical research – gave the Gates Foundation first billing for the joint workshops and meetings held on federal property.




The Gates Foundation did not respond to repeated requests for comment. The NIH also declined to comment.


Leveraging Investments

Like most philanthropies, the Gates Foundation tries to grow its endowment through investments. Some of these efforts, especially its stake in vaccine companies, blur the lines between profit-seeking and the foundation’s mission to develop and deliver vaccines around the world. This symbiotic relationship between capitalism and charity also benefits Gates, whose power and position hinge in large part on the size of his foundation’s assets. Before the pandemic, The Nation magazine reported that the Gates Foundation had a $40 million stake in CureVac – this was not a grant but an investment. CureVac was one of many companies the nonprofit bought stock in that were working on COVID vaccines and therapeutics.

Around that same period, the Gates Foundation announced that it had begun to “leverage a portion of its $2.5 billion Strategic Investment Fund” to advance the nonprofit’s COVID work. The Gates Foundation also turned a $55 million investmentin Pfizer’s COVID vaccine partner, BioNTech, into over $550 million when it sold stock a couple of years later after the vaccine hit the market.

The Bill and Melinda Gates Foundation was established in 2000 with an initial endowment of $20 billion and a primary focus on reducing global health disparities. Rather than working exclusively through non-governmental agencies, the Gates Foundation began contributing to the NIH through the agency’s own nonprofit, the Foundation for the National Institutes of Health (FNIH). Congress created the FNIH in 1990 as a firewall between NIH officials and outside donors seeking to influence federal research.

That firewall is not ironclad. In 2018, for example, NIH officials, funded by beer and liquor companies through an FNIH grant, were in frequent contact with the alcohol industry while designing a study that seemed predetermined to find alcohol’s benefits but not potential harms, such as cancer. The NIH also declined money in 2018 from drugmakers to support a proposed $400 million research program to discover opioid alternatives and addiction treatments. Like the alcohol funds, that drugmaker money would have also been routed through the FNIH.

Major Grants to Government

In 2003, the Gates Foundation donated $200 million to the FNIH to fund NIH scientific programs, an unprecedented sum. Rice University researchers warned in 2008 that this Gates cash was shifting the NIH’s scientific priorities, even though the money was cycled through the FNIH. While FNIH manages and administers Gates money, they said, the Gates Foundation’s scientific board ultimately “oversees and selects the projects to be funded” at the NIH

After Gates gave an NIH lecture in 2013, NIH documents show that the agency began hosting Gates-NIH Workshops, eventually synchronizing federal research programs with Gates, to include coordinating grant funding and science policies across 10 NIH programs.

“Bill Gates, along with the NIH, the Wellcome Trust, it was this cartel,” the whistleblower, a former NIH official who requested anonymity, told RCI. “This is a globalist movement. And that’s something that I don’t think the public knows.”

The Gates Foundation held its second annual meeting with the NIH in July 2105, with both sides proposing new areas of teamwork, and later agreeing to cooperate on funding and research policies for global health. One area of overlap was the West African Ebola outbreaks. To align the Gates Foundation’s Ebola research with the federal agency, Gates routed money through the FNIH so that NIH employees could hire the McKinsey consulting firm.

According to the NIH’s summary of the 2015 workshop, McKinsey’s study of the Ebola field found 20 therapeutics, eight diagnostics, and eight different vaccines, concluding that the Merck and GSK vaccines were the most advanced.



At no point in the several dozen emails and documents provided to RCI did NIH officials appear to raise any concerns about conflicts of interest regarding their work with Gates, nor the hiring of McKinsey to shape federal research and development policies. McKinsey is a global consulting firm whose clients include dozens of foreign governments and some of the world’s largest corporations.

House Democrats released an April 2022 investigation that documented McKinsey’s conflicts of interest during the opioid epidemic that killed tens of thousands of Americans, finding that McKinsey provided consulting advice to both Purdue Pharma and the Food and Drug Administration from 2008 to 2019. In one example, the report surfaced emails with McKinsey employees congratulating themselves for influencing a 2018 speech on opioid safety by then-FDA Commissioner Dr. Scott Gottlieb.


When Congress brought McKinsey managing partner Bob Sternfels before cameras during a 2022 public hearing, he alleged that his firm did not have a conflict of interestwhen it gave simultaneous advice to both OxyContin’s manufacturer and the government agency that regulated OxyContin. Two years later, McKinsey paid a $650 million fine to resolve a criminal and civil investigation into the firm’s consulting work with Purdue Pharma.

“The NIH and BMGF have had a long history of interaction, particularly with respect to vaccines and drugs,” reads the NIH summary of the 2015 Gates-NIH meeting.

A longtime NIH official said that the agency’s leadership initially held Gates at arm’s length, but eventually gave in. “They were very suspicious at first,” said the official, who requested anonymity. “But they got caught up in, ‘Wow, he’s the richest man in the world!”

The NIH official added, “What I saw, which really, I think, extends until this day, is a complete merging of NIH and Gates. And I’ve never seen that written anywhere. I don’t think people realize this incredible symbiotic relationship.”
Bill Gates Is Coming!

Bill Gates added a bit of splendor to the Gates-NIH workshop series when he made his first personal appearance at the April 2016 meeting. As part of the meticulous planning for the event, NIH Director Francis Collins held a 45-minute teleconference10 days prior to hash out the meeting’s details with Trevor Mundel, a former pharmaceutical executive in charge of global health at the Gates Foundation.

According to a list of key “milestones and accomplishments” sent at the time to Collins, the Gates Foundation was by then firmly entwined within the NIH ecosystem to include dual workshops, joint clinical trials, combined research policies, and collaborative funding efforts. For example, NIH staff and Gates employees worked together on clinical trials for TB treatment in Africa. Both Gates and NIH employees also began a joint study for TB with support from the Chinese Ministry of Science and Technology.

The night before the meeting, the NIH held a reception and a catered dinner, paid by the FNIH, for almost two dozen Gates executives at the Cloisters Mansion, a historic, stone castle in rural Maryland, where actor Will Smith married actress Jada Pinkett.

Emails show that the NIH continued scrambling that night to lock down the arrival of other attendees, which included Obama officials at the Department of Health and Human Services and the Commissioner of the Food and Drug Administration, Robert Califf.

To provide Bill Gates a luxury experience, NIH staff prepared Collins – a Nobel Prize-winning scientist – a minute-by-minute itinerary for the arrival of Gates and his retinue the following morning. NIH police were ordered to greet Bill at the facility’s entrance and then escort the billionaire’s three-vehicle convoy the final half mile to one of the main research centers, where the Director lingered in waiting. Such deference to power, said a senior Trump official when reading the Collins itinerary over the phone, is normally reserved for the president, first lady, or visiting dignitaries of state.



“Dr. Collins will meet Bill Gates after he exits the car and steps inside of the building,” the itinerary read. After posing for a photo, Collins was bidden to escort the billionaire into the main auditorium and welcome the audience for Gates.

The agenda shows Collins and Gates Foundation’s Trevor Mundel gave a joint introduction before stepping aside for Bill Gates’s opening speech. Moderated by Dr. Anthony Fauci, the man who would later lead the U.S. medical response to COVID, the first panel included a mix of NIH and Gates executives discussing microbial outbreaks and public-private partnerships to develop pandemic-preventive vaccines.

Collins then moderated a panel on “Research on Engineered Gene Drives and Vector-Borne Disease Control: Status and Next Direction.” Gene drive technology involves inserting specific genetic traits to spread rapidly throughout a population. Gates has long been a fan of gene drives to control mosquitoes, but the technology is highly controversial as it could also drive species to extinction and irrevocably alter ecosystems. The NIH’s scientific program to control mosquitoes with genetic technology was apparently started with seed money from Gates in 2003.

Beginning in 2012, a Bill Gates-funded nonprofit called Target Malaria began a gene drive technology study to eradicate malaria-transmitting mosquitoes in Burkina Faso. Last August, Burkina Faso’s government suspended Target Malaria’s project over safety concerns and worries about the excessive influence of Bill Gates on the country’s sovereignty.


Gates only stayed the morning of the 2016 meeting and left before lunch. “Bill Gates is escorted, by Dr. Collins, out of the building through the same hallway he entered,” reads Collins’ itinerary. “NIH Police escort Mr. Gates and staff to the exit gate.”

The meeting ended with a wrap-up and review of next steps, led by Collins and a Gates executive.

Later that year, the FNIH honored the Bill & Melinda Gates Foundation and Pfizer with an award for supporting the NIH’s mission. Gates was recognized for $413 million dollars in donations and Pfizer for $73 million. In a press release announcing the honor, the NIH said, “Their gifts created cornerstone programs and paved the way for our partnerships with literally hundreds of other organizations dedicated to driving biomedical research worldwide.”



The FNIH continues to maintain close ties to pharmaceutical interests, a major NIH funder. The current CEO, Julie Gerberding, came to the FNIH during the COVID pandemic, having previously served as President of Merck Vaccines.



This article appeared at Brownstone Institute and republished from the author’s Substack


About Paul Thacker
Paul D. Thacker is an Investigative Reporter; Former Investigator United States Senate; Former Fellow Safra Ethics Center, Harvard University
View all posts by Paul Thacker →

Monday, September 21, 2026

MONOPOLY CAPITALI$M

Paramount on track to acquire Warner following a deal with US states


21.09.2026, DPA

Photo: Michael Kappeler/dpa

The entertainment group Paramount has cleared a major hurdle in its takeover of Hollywood rival Warner Brothers.

Paramount reached an agreement on Monday with several US states that had sought to block the deal, worth more than $110 billion dollars, through legal action.

The agreement stipulates that the merged group will invest more money in the US and specifically in Hollywood, said California's Attorney General Rob Bonta. 

A new editorial oversight board has been agreed for the news channel CNN and Paramount's broadcaster CBS News, designed to safeguard their independence.

Paramount's commitment that the studios will release a combined total of 30 films a year in cinemas, at least for the first two years following the merger, has been reaffirmed, according to Bonta.

The financial news service Bloomberg reported that the screenwriters' union is also dropping its lawsuit against the Warner takeover following an agreement with Paramount. Among other things, the studio has agreed to contribute $17.5 million to a healthcare fund for the writers.

The states led by California argued in their antitrust lawsuit that the concentration of economic power at Paramount would harm Hollywood and the cinema business. 

US media reported that Paramount had threatened to begin the process of moving out of California from October onwards if no agreement is reached.

Paramount was taken over just over a year ago by the family of tech billionaire Larry Ellison.

The Warner group also owns the news channel CNN, whose fate has received particular attention in debates surrounding the takeover. CNN often reports critically on US President Donald Trump. Larry Ellison is known as a Trump supporter.

Monday, May 18, 2026

MONOPOLY CAPITALI$M

NextEra Energy and Dominion Energy agree deal


NextEra Energy and Dominion Energy have announced plans to combine in an all-stock transaction valued at about USD66.8 billion that they say will create the world’s largest regulated electric utility business.
 
(Image: NextEra Energy, Dominion Energy logos)

The combined entity will operate under the NextEra name and be 74.5% owned by NextEra Energy shareholders and 25.5% by Dominion Energy shareholders. It will serve around 10 million accounts across Florida, Virginia, North Carolina and South Carolina.

The combined entity will have 110 GW of generating capacity, including considerable nuclear energy capacity - NextEra Energy Resources, along with its affiliate company Florida Power & Light Company, operates seven nuclear units at four sites: Turkey Point and St Lucie in Florida; Seabrook in New Hampshire; and Point Beach in Wisconsin. Additionally, it plans to restart the Duane Arnold plant in Iowa, which ceased operations in 2020. The plant is scheduled to become operational at the beginning of 2029, pending regulatory approvals. A power purchase agreement with Google was announced last October.

In January NextEra Energy said it could add up to 6 GWe of small modular reactor generating capacity at its existing nuclear power plant sites or potential new sites, primarily to meet demand from data centres.

More than 40% of the electricity Dominion Energy generates is from its nuclear plants - Millstone Nuclear Power Station in Connecticut, North Anna and Surry nuclear power plants in Virginia and VC Summer in South Carolina.

John Ketchum, chairman, president and CEO of NextEra Energy, said: "This is a historic moment for our two companies and for the states we are privileged to serve. Electricity demand is rising faster than it has in decades. Projects are getting larger and more complex. Customers need affordable and reliable power now, not years from now. We are bringing NextEra Energy and Dominion Energy together because scale matters more than ever - not for the sake of size, but because scale translates into capital and operating efficiencies. It enables us to buy, build, finance and operate more efficiently, which translates into more affordable electricity for our customers in the long run."

Robert Blue, chair, president and CEO of Dominion Energy, said: "This combination brings together two strong operating platforms and creates an even stronger energy partner for Virginia, North Carolina, South Carolina and Florida, with the scale and balance sheet to deliver the generation, transmission and grid investments our customers and economies need."

The proposal is that Ketchum will serve as chairman and CEO of the combined company and Blue will serve as president and CEO of regulated utilities and as a member of the board of directors. The combined company's board of directors will include 10 directors from NextEra Energy and four from Dominion Energy. The announcement includes a proposal for USD2.25 billion in bill credits for Dominion customers in Virginia, North Carolina and South Carolina over the two years after the deal closes.

The two sides expect the deal to close in 12 to 18 months "subject to customary closing conditions and approvals by the shareholders of NextEra Energy and Dominion Energy, the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, approval by the Federal Energy Regulatory Commission under Section 203 of the Federal Power Act and approval by the Nuclear Regulatory Commission".

NextEra-Dominion Energy Merger To Create World’s Largest Electric Utility

Leading clean energy utility, NextEra Energy (NYSE:NEE), has agreed to buy Dominion Energy (NYSE:D) in an all-stock transaction valued at $66.8 billion, marking the largest power utility acquisition on record. The merger unites Florida-based NextEra Energy and Virginia-based Dominion Energy to create the world’s largest regulated electric utility, a power sector titan with an enterprise value exceeding $400 billion including debt.

The historic consolidation is directly driven by the artificial intelligence infrastructure boom, with high-performance AI hardware having triggered a massive surge in electricity demand. NextEra, a global leader in wind and solar power, will leverage its clean energy assets to meet the carbon-free electricity requirements of tech hyperscalers like Alphabet (NASDAQ:GOOG), Microsoft (NASDAQ:MSFT), Amazon (NASDAQ:AMZN) and Meta Platforms (NASDAQ:META).

NextEra previously secured high-profile deals, including an agreement with Google to revive Iowa’s Duane Arnold nuclear plant.

Dominion operates in Virginia and the Carolinas, with Northern Virginia home to the world’s largest concentration of data centers, also known as the “Data Center Alley”.

PJM Interconnection, the largest U.S. power grid operator, has projected that summer peak demand in the Dominion Energy zone (encompassing Northern Virginia’s Data Center Alley) to grow by 5.4% annually over the next decade. Because hyperscale data centers run continuously at high load factors, they drive up demand evenly, causing winter peak loads to rise at a 4% annualized rate.

However, the mega-merger faces a complex review process since it requires antitrust clearance and approvals from the Federal Energy Regulatory Commission (FERC) alongside state public utility commissions in Florida, Virginia, and the Carolinas.

Thankfully, Wall Street is generally bullish that the current federal administration’s general openness to corporate mergers may provide a smoother path toward finalization.

By Alex Kimani for Oilprice.com


NextEra to Buy Dominion in Landmark U.S. Utility Mega-Merger

Under the agreement, Dominion shareholders will receive 0.8138 shares of NextEra Energy for each Dominion share they own, giving NextEra investors roughly 74.5% ownership of the combined company and Dominion shareholders about 25.5%. The transaction is expected to close within 12 to 18 months, pending shareholder and regulatory approvals.

The combined company would serve around 10 million customer accounts across Florida, Virginia, North Carolina, and South Carolina and control approximately 110 gigawatts of generation capacity spanning natural gas, nuclear, renewables, and battery storage. The companies said more than 80% of the merged business would be regulated operations.

The deal comes as U.S. utilities race to secure scale and capital to meet rapidly rising electricity demand driven by artificial intelligence, data centers, industrial reshoring, and electrification trends. NextEra said the combined company would have more than 130 GW of large-load opportunities in its development pipeline.

To ease regulatory and political concerns over customer impacts, the companies proposed $2.25 billion in bill credits for Dominion customers in Virginia, North Carolina, and South Carolina over two years after closing. They also pledged to retain dual headquarters in Juno Beach, Florida, and Richmond, Virginia, while maintaining Dominion’s regional utility brands.

NextEra Chief Executive John Ketchum said the transaction was designed to improve operating efficiency and lower long-term customer costs as utilities face increasingly complex and capital-intensive infrastructure needs. Dominion CEO Robert Blue said the merger would strengthen the companies’ ability to fund new generation, transmission, and grid upgrades.

The companies expect the merger to immediately boost adjusted earnings per share and project more than 9% annual adjusted EPS growth through 2032. They also said the larger balance sheet could improve credit metrics and lower financing costs.

The merger would significantly expand NextEra’s already dominant position in U.S. power markets. The company is currently the largest renewable energy and battery storage developer in the world through NextEra Energy Resources, while Dominion brings major regulated utility operations and one of the largest offshore wind development portfolios in the United States.

The transaction will require approval from the Federal Energy Regulatory Commission, the Nuclear Regulatory Commission, and multiple state utility regulators, including commissions in Virginia, North Carolina, and South Carolina.

By Charles Kennedy for Oilprice.com

Sunday, May 17, 2026

GREEN CAPITALI$M

Are solar panel prices about to surge? Why now might be the perfect time to invest

A team of solar installers set up a new rooftop solar system at a home in Manila, Philippines, on May 1, 2026.
Copyright Copyright 2026 The Associated Press. All rights reserved.


By Liam Gilliver
Published on

Geopolitical uncertainty, supply shortages and China’s recent tax reform are threatening to send the prices of solar panels soaring. But, is it really that severe?

Once an extortionate investment reserved for the ‘eco-elite’, solar has rapidly become one of the cheapest electricity sources in the world. But, are the tables about to turn?

Solar photovoltaic (PV) panels, composed of individual solar cells that convert sunlight into electricity, have plummeted in price by a staggering 90 per cent in the last decade. According to Our World In Data, costs have dropped by around 20 per cent every time the global cumulative capacity doubles.

At the same time, the price of solar batteries, which allow households to store electricity during peak times, have also decreased by 90 per cent since 2010 due to advances in battery chemistry and manufacturing.

The EU now describes solar as a “shining star” of Europe’s clean transition, accounting for almost a quarter (23.4 per cent) of its electricity consumption in 2024. In June last year, the sun was the main source of the electricity generated in the EU.

Amid the war on Iran, solar is helping to cushion households from volatile fossil fuel shocks. Recent analysis found that harnessing sunlight for power saved Europe more than €100 million per day throughout March by reducing gas imports.

If prices remain high, due to Iran’s stranglehold on the Strait of Hormuz, experts say these savings could reach €67.5 billion by the end of the year.

The ongoing conflict in the Middle East has also bolstered interest in household electrification, with multiple energy firms across Europe reporting a recent spike in solar panel and solar battery inquiries.

However, as demand for solar panels soars, foreign tax policy, the price of silver and other influences could soon ignite a price surge.

Where does Europe get its solar panels from?

While the EU describes solar as having a “significant role in its transition towards cleaner, more affordable and secure” energy, it remains heavily reliant on countries outside of the bloc to make PV panels.

In 2024, the EU imported €14.6 billion in green energy products, including €11.1 billion worth of solar panels. China was by far the largest supplier of these panels, accounting for 98 per cent of all imports.

According to the International Energy Agency (IEA), China has invested more than $50 billion (€43 billion) in new PV supply capacity – 10 times more than Europe – and created more than 300,000 manufacturing jobs across the solar PV value chain since 2011. Today, the country’s share in all of the manufacturing stages of solar panels exceeds 80 per cent globally.

“Chinese manufacturers have reached scale and cost levels that cannot be matched outside of China,” Jannik Schall of clean tech startup 1KOMMA5° tells Euronews Earth.

“There are factories in other countries, even in Europe, but they only focus on the final assembly of solar panels and cannot compete with China from a cost perspective.”

China’s monopoly on solar panels hasn’t been a clear victory for the country, with tight competition pushing companies to sell below cost. An IEA report from last year found that China-based solar companies had made cumulative net losses of around $5 billion (€4.3 billion) since the beginning of 2024.

This led to China’s Ministry of Finance and State Tax Administration announcing major reform to its generous renewables subsidies, which were originally designed to support foreign trading.

From 1 April 2026, the nine per cent VAT export rebate on solar products was eliminated, while the nine per cent VAT export rebate on battery products was reduced to six per cent. The VAT rebate on battery products will be completely scrapped from 1 January 2027.

Graph detailing China's solar exports.
Graph detailing China's solar exports. Ember

Just before the tax reform came into place, Chinese solar exports skyrocketed as countries scrambled to beat the price hike.

Energy think-tank Ember found that during March 2026, several European countries, including France, Italy, Poland and Romania, hit all-time records for the number of Chinese solar imports.

Will China’s VAT reform increase the cost of solar?

“The elimination of China’s VAT export rebates alone will cause module prices to rise by around 10 per cent,” Schall tells Euronews Earth. Solar modules is the standard-industry term for a single PV unit.

British newspaper The i has warned that one national solar installer has been forced to charge £800 (€918) more for an average rooftop installation.

So is a blanket price rise expected across the board? It’s not that simple.

Experts say that the market does not react this quickly, and the increasing price of solar panels won’t bite straight away.

Analysts do not expect the rise in cost to limit demand for solar, given its competitive pricing, either. However, it does demonstrate that even renewables are not completely shielded from the intricacies of geopolitics – an argument that frequently arises when speaking about fossil fuel shocks.

InfoLink Consulting, a Taipei-based firm that provides market intelligence, price forecasting and supply chain analysis for solar PV, says that while ground-mounted projects (often used in large-scale solar farms) have edged up in recent weeks, high order volumes have constrained any rise in average prices.

Meanwhile, the price of small-scale or ‘distributed’ solar power systems, like those installed directly on rooftops or carports, has continued to fall marginally, InfoLink said earlier this week (13 May).

How silver became solar’s crux

To understand why solar costs fluctuate, it’s important to understand how PV panels are designed.

Solar panels are predominantly made of glass, plastic polymer and aluminum. Silver, which is the most effective metallic conductor of electricity and heat, is also a key material for PV panels.

Despite representing less than five per cent of a total PV panel in terms of weight, silver paste accounts for up to 30 per cent of total solar cell costs, analysts at German technology group Heraeus state.

According to the Silver Institute, around 4,000 tonnes of silver, equivalent to 14 per cent of global silver consumption, were used for PV panel production in 2023 alone. Researchers warn this share is expected to increase to 20 per cent by 2030, a fourfold increase since 2014.

Chinese manufacturers have therefore been boosting efforts to tackle this, by replacing silver with cheaper metals such as copper. Experts predict switching from silver to copper-based metallisation could save the solar industry roughly $15 billion (€12.8 billion) per year globally.

However, the price of copper has also increased in recent years, albeit at a slower pace than silver.

“Driven by geopolitical uncertainty, supply shortages and increasing demand from AI data centres, prices for copper, aluminum and lithium have increased significantly since Q4 of 2025,” Schall explains.

“Silver prices have reached 150+ per cent increases within a few weeks in the beginning of 2026, making silver the biggest cost contributor in solar panels. These cost increases on the raw material side need time to trickle down through the value chain and are expected to reach end consumers this summer

1KOMMA5° forecasts that the additional high raw material costs, alongside China’s VAT elimination, could cause price increases of 15 to 20 per cent for individual components.

Schall adds that while residential customers will be affected by this in the “medium term” those wanting to install PV panels can still benefit from “more favourable prices” right now.

Euronews Earth reached out to two energy firms in Europe to ask whether they intend to raise their solar panel prices following China’s tax reform and the increasing price of silver. Both declined to comment.

Despite uncertainty, experts point out that solar prices are still around 50 per cent down compared to 2023, making it one of the cheapest sources of electricity in the world.

Monday, March 23, 2026

STATE MONOPOLY CAPITALI$M

Zijin Gold acquires control of rival Chifeng in $2.6B deal


Porgera gold mine, acquired from Barrick in 2020. (Image courtesy of Zijin.)

Zijin Gold is acquiring a controlling stake in Chifeng Jilong Gold Mining for 18.26 billion yuan ($2.64 billion), reinforcing its position as China’s largest gold producer.

The unit of Zijin Mining Group (HKG: 2899) will purchase existing mainland-listed shares and newly issued Hong Kong shares, lifting its interest to nearly 26% and securing effective control with full financial consolidation, the companies said. Chifeng sold about 14.4 tonnes of gold last year from operations in China, Ghana and Laos, compared with Zijin Gold’s 46.6 tonnes.

Zijin will assume operational control of Chifeng, “further solidifying its position as China’s top gold miner,” Bloomberg Intelligence analysts said in a note on Monday. They added the target will benefit from improved efficiency under Zijin’s management.

The deal follows Zijin Gold’s C$5.5 billion ($4 billion) acquisition of Allied Gold (TSX, NYSE: AAUC) and reflects a broader push by Chinese miners to expand output and secure overseas assets amid strong bullion prices and constrained global supply.

Zijin Gold and other Chinese bullion miners including Shandong Gold Mining are poised to outperform global peers after a record 2025, driven by higher prices and rising production, even as gold retreats more than 10% from late-February highs above $5,000 an ounce.

Ongoing geopolitical tensions and safe-haven demand continue to underpin the market, while international rivals face declining output and thinner project pipelines.

Thursday, March 12, 2026

CRIMINAL  MONOPOLY CAPITALI$M

Ticketmaster parent execs privately laugh over price-gouging: 'These people are so stupid'


Matthew Chapman
March 12, 2026
RAW STORY




Vancouver, CANADA - Dec 3 2022 : Twitter account of popular US singer-songwriter Taylor Swift in Twitter website seen in iPhone on Live Nation logo background. (Photo: Koshiro K/Shutterstock)

Newly revealed internal communications show a pair of executives at entertainment venue giant Live Nation laughing about how much they are able to gouge people for concert tickets.

"In a series of chats from 2022, Ben Baker and Jeff Weinhold, two regional directors of ticketing for Live Nation amphitheaters, boasted about their ability to raise so-called 'ancillary fees' – like parking, lawn chair rentals and VIP access – and still get concertgoers to pay for them," reported Bloomber News. "In one exchange, Weinhold gloated about raising VIP parking costs at a Virginia concert venue to $250. 'These people are so stupid. I almost feel bad taking advantage of them,' Baker wrote, adding later, 'I gouge them on ancil prices.' In another exchange, he bragged about charging '$50 to park in the grass' and '$60 for closer grass.'"

“Robbing them blind, baby, that’s how we do it,” Baker wrote.

Live Nation has been accused in a series of lawsuits of holding a monopoly over venues, that squeezes both performers and ticketholders alike — resulting in people being charged hundreds or thousands of dollars more than reasonable to see concerts, shows, and performances around the country. They also own the booking platform Ticketmaster, which has infamously hiked booking fees to higher and higher levels over the years, and can often be the only way to book tickets for Live Nation owned venues. The fiasco surrounding tickets for Taylor Swift's Eras Tour brought many of these issues into national focus.

The company has also been accused in litigation of stonewalling congressional investigators.


This comes as the Trump administration Justice Department's antitrust division reached a settlement with Live Nation, which requires them to pay $200 million to several states, allow third-party sellers access to Ticketmaster, limit their exclusivity agreements, divest 10 of its amphitheaters, and cap service fees for amphitheater tickets to 15 percent of ticket price.

This settlement has been rejected by over two dozen state attorneys general as inadequate to resolve Live Nation's monopoly power, since it doesn't require Ticketmaster to be divested altogether, and state-level litigation is expected to continue.

Monday, March 09, 2026


Live Nation settles antitrust case with US Justice Dept, states object


By AFP
March 9, 2026


Live Nation has reached a tentative settlement with the Justice Department in the antitrust case brought against the US entertainment giant - Copyright AFP/File Giuseppe CACACE

Live Nation reached a tentative settlement with the US Justice Department on Monday in the federal antitrust case brought against the entertainment giant, a senior official said.

The settlement, which still requires the approval of a judge, comes just days after the start of an antitrust trial against Live Nation in New York.

The case was initiated under then-president Joe Biden when the Justice Department labeled Live Nation a monopolist that controlled virtually all live entertainment in the United States.

The settlement requires Live Nation, which owns Ticketmaster, to open up the ticketing platform to competitors and to allow other concert promotors to stage events at certain Live Nation venues, the official said.

Live Nation will also divest up to 13 amphitheaters and pay $280 million in damages to the nearly 40 states that were parties to the antitrust lawsuit against the California-based company.

New York and a number of other states declined to join the settlement, however, and said Monday that their litigation would continue.

“For years, Live Nation has made enormous profits by exploiting its illegal monopoly and raising costs for shows,” New York Attorney General Letitia James said.

“The settlement recently announced with the US Department of Justice fails to address the monopoly at the center of this case, and would benefit Live Nation at the expense of consumers,” James said in a statement.

“We will keep fighting this case without the federal government so that we can secure justice for all those harmed by Live Nation’s monopoly.”

Live Nation is a behemoth in its industry: in 2025 it organized more than 55,000 events worldwide, drawing 159 million attendees.

Beyond promotion, it holds stakes in 460 venues and, since 2010, has controlled Ticketmaster, the world’s leading ticket seller.

The Justice Department had accused Live Nation of abusing its dominant position to pressure artists and venues into signing with it, stifle competition, and impose excessive fees on fans.

The Trump administration’s decision to press forward with the case against Live Nation had surprised many observers, who had interpreted last month’s resignation of Justice Department competition chief Gail Slater as a sign the case would be dropped.


‘While No One’s Looking,’ Trump DOJ Settles Antitrust Case With Live Nation-Ticketmaster

“This settlement is the clearest sign yet that this administration serves big business, not the people.”


The Ticketmaster logo appears on a smartphone screen in the Apple app store on on March 6, 2026.
(Photo by Thomas Fuller/NurPhoto via Getty Images)


Jake Johnson
Mar 09, 2026
COMMON DREAMS

 Trump Justice Department on Monday reportedly reached a tentative deal with Live Nation—the owner of Ticketmaster—to settle a Biden-era antitrust lawsuit that aimed to break up the company, accusing it of illegally monopolizing the live entertainment industry.

News of the settlement, which would not require a breakup of Live Nation, came days after the trial began, with a lawyer for the Trump Justice Department’s decimated antitrust division saying last week that the company abuses its market power and earns its massive profits “through illegal action.” The antitrust division’s counsel in the case, David Dahlquist, was apparently not made aware of the settlement until he appeared in court Monday morning.

Lee Hepner, senior legal counsel at the American Economic Liberties Project, said it is “highly unorthodox for the Justice Department’s lead litigator to be left out of the loop on the settlement and highly prejudicial to the jury’s deliberations.”

“According to every observer, this trial was already going well for the Justice Department and states,” said Hepner. “They had just won summary judgment and a jury had already heard evidence of Live Nation’s longstanding pattern of retaliation against venues who had attempted to open the market to competition. State AGs are once again left to clean up the mess left by this Administration’s incompetence.”

Under the settlement, which must be approved by a judge, Live Nation “would pay a fine of up to $280 million and divest itself of at least 13 amphitheaters across the country as it opens up its ticketing processes so that competitors can share in the sale of tickets,” the Associated Press reported.

The National Independent Venue Association (NIVA), a trade group representing thousands of independent live entertainment venues, festivals, and promoters, noted in a statement that the reported $280 million settlement amount “is the equivalent of four days of [Live Nation’s] 2025 revenue, which means they could potentially make it back by this Friday.”

“The reported settlement does not appear to include any specific and explicit protections for fans, artists, or independent venues and festivals,” said Stephen Parker, NIVA’s executive director. “Reported details also indicate that ticket resale platforms could be further empowered through new requirements for Ticketmaster to host their listings, which would likely exacerbate the price gouging potential for predatory resellers and the platforms that serve them.”

“If these facts are true,” Parker added, “NIVA views this as a failure of the justice system.”

The antitrust lawsuit against Live Nation was filed in 2024 after a nearly two-year investigation launched amid mounting public outrage aimed at Ticketmaster, spurred in part by its botched presale of Taylor Swift concert tickets in 2022. Then-President Joe Biden’s Justice Department filed the complaint in partnership with 30 state attorneys general, most of whom vowed Monday to continue the fight without the Trump administration’s support.

“For years, Live Nation has made enormous profits by exploiting its illegal monopoly and raising costs for shows,” said New York Attorney General Letitia James. “My office has led a bipartisan group of attorneys general in suing Live Nation for taking advantage of fans, venues, and artists, and we are committed to holding Live Nation accountable.”

The settlement deal comes weeks after Gail Slater, the former head of the Justice Department’s antitrust arm, was pushed out by DOJ leadership. Prior to Slater’s removal, Live Nation executives and lobbyists had reportedly been negotiating the terms of a possible settlement with senior Justice Department officials outside of the antitrust office, heightening corruption concerns.

Emily Peterson-Cassin, policy director at the Demand Progress Education Fund, said in a statement that “this settlement amounts to a slap on the wrist that tinkers around the edges of the real problem: Live Nation’s monopoly.”

“Instead of breaking up Live Nation and Ticketmaster, Live Nation will now get to continue forcing the vast majority of live venues to use Ticketmaster,” said Peterson-Cassin. “Following the ousting of Gail Slater and the gutting of the government’s antitrust enforcement capabilities, this settlement is the clearest sign yet that this administration serves big business, not the people.”